Published by
@ShahidNShah
@ShahidNShah
June 11 to June 13, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The 4th Tumor Myeloid Targeting Therapies Summit 2024, scheduled from June 11th to 13th, 2024, highlights the burgeoning landscape of innate immune cells in clinical applications. Recent studies emphasize the efficacy of targeting myeloid cells to shrink tumors, enhancing confidence in their therapeutic potential. This annual summit convenes innate immunity experts from biopharma and academia to showcase novel clinical practices across multiple myeloid subsets, including macrophages, MDSCs, neutrophils, and dendritic cells. Attendees will learn about translational lessons, novel targets, and the complexities of the tumor microenvironment from leading institutions and companies such as MD Anderson, Gilead Sciences, Onchilles Pharma, DEM Biopharma, and NGM Biopharma.
[Read on tumor-myeloid-therapeutics.com/](https://tumor-myeloid-therapeutics.com/)
Continue reading at tumor-myeloid-therapeutics.com
June 11, 2024
Mayo Clinic, Siebens Building, 100 2nd Avenue Southwest Phillips Hall, Rochester, Minnesota, 55902, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 15, 2024 at 12:42pm